| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 267,960 | 282,132 | ||
| Marketable securities | 807,010 | 868,205 | ||
| Prepaid expenses and other current assets | 23,577 | 25,127 | ||
| Total current assets | 1,098,547 | 1,175,464 | ||
| Total property and equipment | 196,891 | - | ||
| Less accumulated depreciation | 88,601 | - | ||
| Property and equipment, net | 108,290 | 108,824 | ||
| Restricted cash | 6,656 | 6,633 | ||
| Operating lease right-of-use assets | 96,995 | 99,568 | ||
| Other assets | 593 | 668 | ||
| Total assets | 1,311,081 | 1,391,157 | ||
| Accounts payable | 9,545 | 10,556 | ||
| Accrued expenses and other current liabilities | 42,314 | 40,904 | ||
| Current portion of derivative liabilities | 6,500 | 3,900 | ||
| Current portion of deferred revenue | 110,320 | 105,822 | ||
| Current portion of lease liability | 12,688 | 12,949 | ||
| Current portion of consideration liabilities | 1,192 | - | ||
| Total current liabilities | 182,559 | 174,131 | ||
| Long-term lease liability | 138,732 | 141,854 | ||
| Long-term portion of contingent consideration liabilities | 6,708 | 1,186 | ||
| Long-term portion of deferred revenue | 10,160 | 20,319 | ||
| Long-term portion of derivative liabilities | 6,654 | 6,497 | ||
| Other liabilities | 266 | 357 | ||
| Total liabilities | 345,079 | 344,344 | ||
| Common stock, 0.01 par value 250,000,000 shares authorized, 101,359,765 and 83,633,069 issued and outstanding at and september 30, 2025 and december 31, 2024, respectively | 1,014 | 1,008 | ||
| Additional paid-in capital | 2,855,118 | 2,823,987 | ||
| Accumulated other comprehensive (loss) income | 790 | 10 | ||
| Accumulated deficit | -1,890,920 | -1,778,192 | ||
| Total stockholders' equity | 966,002 | 1,046,813 | ||
| Total liabilities and stockholders' equity | 1,311,081 | 1,391,157 | ||
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)